| 51.63 BATS BZX Real-Time Price As of 1:29pm ET |  +0.03 / +0.06%Today’s Change | 29.23 Today|||52-Week Range 58.38 | +65.59% Year-to-Date |
| JAZZ vs. CTLT: Which Stock Is the Better Value Option? Sep 06 / Zacks.com - Paid Partner Content |
| Previous close | 51.60 |
| Today’s open | 51.63 |
| Day’s range | 51.29 - 52.08 |
| Volume | 302,815 |
| Average volume (3 months) | 756,711 |
| Market cap | $7.4B |
| Earnings growth (last year) | +42.98% |
| Earnings growth (this year) | +8.87% |
| Earnings growth (next 5 years) | +11.00% |
| Revenue growth (last year) | +2.22% |
| P/E ratio | 57.4 |
| Price/Sales | 3.14 |
| Price/Book | 4.40 |
| Today’s change | Today’s % change | |
|---|---|---|
| PRGOPerrigo Company PLC | -0.84 | -1.52% |
| JAZZJazz Pharmaceuticals... | -0.93 | -0.72% |
| BHCValeant Pharmaceutic... | -0.21 | -0.92% |
| SAGESAGE Therapeutics In... | -3.34 | -2.02% |
| Next reporting date | November 11, 2019 |
| EPS forecast (this quarter) | $0.25 |
| Annual revenue (last year) | $2.5B |
| Annual profit (last year) | $132.0M |
| Net profit margin | 5.24% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman & Chief Executive Officer John R. Chiminski |
President & Chief Operating Officer Alessandro Maselli |
Corporate headquarters Somerset, New Jersey |
